Beduneau A[au] - Search Results

Year	Number of Results
2006	1
2007	4
2008	1
2009	2
2010	1
2011	1
2012	5
2013	4
2014	4
2015	4
2016	3
2017	1
2018	2
2019	1
2020	6
2021	5
2022	5
2023	1

1

Interaction and toxicity of ingested nanoparticles on the intestinal barrier.

Stalder T, Zaiter T, El-Basset W, Cornu R, Martin H, Diab-Assaf M, Béduneau A. Stalder T, et al. Among authors: beduneau a. Toxicology. 2022 Nov;481:153353. doi: 10.1016/j.tox.2022.153353. Epub 2022 Oct 17. Toxicology. 2022. PMID: 36257551 Review.

2

Amelioration of murine experimental colitis using biocompatible cyclosporine A lipid carriers.

Scarcello E, Abdel-Mottaleb MMA, Beduneau A, Moulari B, Pellequer Y. Scarcello E, et al. Among authors: beduneau a. Drug Deliv Transl Res. 2021 Jun;11(3):1301-1308. doi: 10.1007/s13346-020-00835-z. Drug Deliv Transl Res. 2021. PMID: 32794147

3

Ingestion of titanium dioxide nanoparticles: a definite health risk for consumers and their progeny.

Cornu R, Béduneau A, Martin H. Cornu R, et al. Among authors: beduneau a. Arch Toxicol. 2022 Oct;96(10):2655-2686. doi: 10.1007/s00204-022-03334-x. Epub 2022 Jul 27. Arch Toxicol. 2022. PMID: 35895099 Review.

4

Influence of nanoparticles on liver tissue and hepatic functions: A review.

Cornu R, Béduneau A, Martin H. Cornu R, et al. Among authors: beduneau a. Toxicology. 2020 Jan 30;430:152344. doi: 10.1016/j.tox.2019.152344. Epub 2019 Dec 13. Toxicology. 2020. PMID: 31843632 Review.

5

Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting.

Ries M, Moulari B, Shetab Boushehri MA, Ali ME, Molnar D, Béduneau A, Pellequer Y, Lamprecht A. Ries M, et al. Among authors: beduneau a. Pharmaceutics. 2022 Feb 2;14(2):352. doi: 10.3390/pharmaceutics14020352. Pharmaceutics. 2022. PMID: 35214083 Free PMC article.

6

Active targeting of brain tumors using nanocarriers.

Béduneau A, Saulnier P, Benoit JP. Béduneau A, et al. Biomaterials. 2007 Nov;28(33):4947-67. doi: 10.1016/j.biomaterials.2007.06.011. Epub 2007 Aug 22. Biomaterials. 2007. PMID: 17716726 Review.

7

Nanoparticle targeting to inflamed tissues of the gastrointestinal tract.

Moulari B, Beduneau A, Pellequer Y, Lamprecht A. Moulari B, et al. Among authors: beduneau a. Curr Drug Deliv. 2013 Feb;10(1):9-17. doi: 10.2174/1567201811310010004. Curr Drug Deliv. 2013. PMID: 22998041 Review.

8

Investigation of the spontaneous nanoemulsification process with medium- and long-chain triglycerides.

Jamoussi Y, Zaiter T, Desrumaux C, Acar N, Pellequer Y, Béduneau A. Jamoussi Y, et al. Among authors: beduneau a. Colloids Surf B Biointerfaces. 2021 Jan;197:111432. doi: 10.1016/j.colsurfb.2020.111432. Epub 2020 Oct 27. Colloids Surf B Biointerfaces. 2021. PMID: 33166936

9

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides.

Shetab Boushehri MA, Abdel-Mottaleb MMA, Béduneau A, Pellequer Y, Lamprecht A. Shetab Boushehri MA, et al. Among authors: beduneau a. Drug Deliv. 2018 Nov;25(1):1414-1425. doi: 10.1080/10717544.2018.1469684. Drug Deliv. 2018. PMID: 29902933 Free PMC article.

10

Size effect and mucus role on the intestinal toxicity of the E551 food additive and engineered silica nanoparticles.

Zaiter T, Cornu R, Millot N, Herbst M, Pellequer Y, Moarbess G, Martin H, Diab-Assaf M, Béduneau A. Zaiter T, et al. Among authors: beduneau a. Nanotoxicology. 2022 Mar;16(2):165-182. doi: 10.1080/17435390.2022.2063084. Epub 2022 May 17. Nanotoxicology. 2022. PMID: 35579945

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results